Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
暂无分享,去创建一个
F. van Leth | A. Copas | A. Yavlinsky | R. Diel | M. Noursadeghi | D. Roth | J. Johnston | A. Hauri | S. Geis | G. Sotgiu | I. Abubakar | M. Rangaka | T. Yoshiyama | J. Zellweger | R. Aldridge | M. Lipman | K. Romanowski | C. Calderwood | J. Domínguez | J. Doyle | Rishi K. Gupta | M. Quartagno | C. Lange | G. Woltmann | P. Haldar | M. Sester | C. Dobler | R. Sloot | D. Zenner | C. Erkens | N. Altet | B. Lange | L. Muñoz | M. C. Aichelburg | M. Krutikov | T. Hermansen | C. Roder | Matteo Quartagno
[1] Paul C. Lambert,et al. Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study , 2019, Commun. Stat. Simul. Comput..
[2] J. Campbell,et al. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis , 2020, BMJ.
[3] H. Zar,et al. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis , 2020, The Lancet.
[4] C. Jackson,et al. Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study , 2020, Annals of the American Thoracic Society.
[5] Gibril J. Njie,et al. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[6] Ruoran Li,et al. Two Clinical Prediction Tools to Improve Tuberculosis Contact Investigation , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] Eric S. Ramos,et al. A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study , 2020, The Lancet. Infectious diseases.
[8] J. Deeks,et al. Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study. , 2019, American journal of respiratory and critical care medicine.
[9] Andrew J. Vickers,et al. A simple, step-by-step guide to interpreting decision curve analysis , 2019, Diagnostic and Prognostic Research.
[10] Gerta Rücker,et al. How to perform a meta-analysis with R: a practical tutorial , 2019, Evidence-Based Mental Health.
[11] C. Jackson,et al. Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort. , 2019, The Journal of infectious diseases.
[12] Carolin T. Turner,et al. Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis , 2019, bioRxiv.
[13] B. Chain,et al. Blood transcriptomic stratification of short-term risk in contacts of tuberculosis. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Deeks,et al. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study , 2019 .
[15] M. Behr,et al. Revisiting the timetable of tuberculosis , 2018, British Medical Journal.
[16] D. Sherman,et al. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection , 2018, Clinical Microbiology Reviews.
[17] Cyril Ferdynus,et al. Decision curve analysis: a technical note. , 2018, Annals of translational medicine.
[18] S. Self,et al. Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents , 2018, The New England journal of medicine.
[19] Karel G M Moons,et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model , 2018, The Lancet Neurology.
[20] Richard A. White,et al. Stratification by interferon-γ release assay level predicts risk of incident TB , 2018, Thorax.
[21] Jiawei Li,et al. Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy , 2018, Journal of Translational Medicine.
[22] Richard D Riley,et al. Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C-statistic and calibration measures? , 2017, Statistical methods in medical research.
[23] L. Moulton,et al. A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study , 2017, The Lancet. Infectious diseases.
[24] Ross J. Harris,et al. Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis. , 2017, Annals of internal medicine.
[25] Ross J. Harris,et al. Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation , 2017, European Respiratory Journal.
[26] J. Andrews,et al. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. , 2017, The Lancet. Respiratory medicine.
[27] V. Cook,et al. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study , 2017, European Respiratory Journal.
[28] Vincent Audigier,et al. Multiple Imputation for Multilevel Data with Continuous and Binary Variables , 2017, 1702.00971.
[29] H. Alsdurf,et al. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.
[30] F. Cobelens,et al. Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands , 2016, European Respiratory Journal.
[31] Richard D Riley,et al. Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings. , 2016, Journal of clinical epidemiology.
[32] B. Kampmann,et al. The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection , 2016, Thorax.
[33] Frank E. Harrell,et al. Prediction models need appropriate internal, internal-external, and external validation. , 2016, Journal of clinical epidemiology.
[34] V. Cook,et al. Knowledge and Perceptions of Latent Tuberculosis Infection among Chinese Immigrants in a Canadian Urban Centre , 2015, International journal of family medicine.
[35] Ross J. Harris,et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries , 2015, European Respiratory Journal.
[36] Johannes B. Reitsma,et al. Individual Participant Data (IPD) Meta-analyses of Diagnostic and Prognostic Modeling Studies: Guidance on Their Use , 2015, PLoS medicine.
[37] T. Yoshiyama,et al. Use of the QuantiFERON®-TB Gold in Tube test for screening TB contacts and predictive value for active TB , 2015, Infectious diseases.
[38] R. Chaisson,et al. Latent Mycobacterium tuberculosis infection. , 2015, The New England journal of medicine.
[39] R. Duarte,et al. Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study. , 2015, American journal of respiratory and critical care medicine.
[40] A. Orcau,et al. Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing. , 2015, Annals of the American Thoracic Society.
[41] Richard D Riley,et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .
[42] J. Castellote,et al. Immunodiagnostic Tests’ Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study , 2015, Transplantation direct.
[43] I. Abubakar,et al. Treatment of Latent Tuberculosis Infection , 2015, Annals of Internal Medicine.
[44] G. Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement , 2015, BMJ : British Medical Journal.
[45] F. van Leth,et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. , 2014, American journal of respiratory and critical care medicine.
[46] P. Kouw,et al. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. , 2014, American journal of respiratory and critical care medicine.
[47] Yvonne Vergouwe,et al. Towards better clinical prediction models: seven steps for development and an ABCD for validation. , 2014, European heart journal.
[48] J. Denholm,et al. Latent Tuberculosis Screening Using Interferon-Gamma Release Assays in an Australian HIV-Infected Cohort: Is Routine Testing Worthwhile? , 2014, Journal of acquired immune deficiency syndromes.
[49] M. Pai,et al. Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection , 2014, Clinical Microbiology Reviews.
[50] A. Hauri,et al. How can we achieve better prevention of progression to tuberculosis among contacts? , 2013, European Respiratory Journal.
[51] G. Marks,et al. Risk of tuberculosis among contacts in a low-incidence setting , 2012, European Respiratory Journal.
[52] E. W. Hoskyns,et al. Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk , 2012, Thorax.
[53] W. Kern,et al. Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[54] M. Pai,et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.
[55] Patrick Royston,et al. Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.
[56] Jörg Drechsler,et al. Multiple Imputation for Nonresponse , 2011 .
[57] S. Niemann,et al. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. , 2011, American journal of respiratory and critical care medicine.
[58] F. Cobelens,et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement , 2009, European Respiratory Journal.
[59] A. Rieger,et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] M. Pai,et al. Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[61] S. Egwaga,et al. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] P. Royston,et al. Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects , 2002, Statistics in medicine.